Stocks and Investing Stocks and Investing
Tue, April 5, 2022
[ 12:00 AM ] - WOPRAI
Daniel Oppenheim Initiated (TREX) at Sell and Held Target at $65 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
David Motemaden Maintained (TRV) at Hold and Held Target at $179 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (TRV) at Hold and Held Target at $172 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Matt Olney Maintained (TCBX) at Buy with Decreased Target to $28 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Initiated (TASK) at Hold and Held Target at $42 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Balaji Prasad Upgraded (TEVA) to Buy and Increased Target to $13 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TEL) at Buy and Held Target at $153 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Oppenheim Initiated (SWK) at Buy and Held Target at $165 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Initiated (STNE) at Hold and Held Target at $13 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Corinne Blanchard Maintained (SQM) at Strong Buy with Increased Target to $98 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Brett Knoblauch Initiated (SPT) at Buy and Held Target at $99 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Initiated (SQ) at Buy and Held Target at $165 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Eugene Simuni Initiated (SOFI) at Strong Buy and Held Target at $13 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Ike Boruchow Downgraded (VFC) to Hold and Decreased Target to $58 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Chris Terry Downgraded (VALE) to Hold and Increased Target to $22 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Mircea Dobre Maintained (URI) at Hold and Held Target at $328 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Phil Gresh Maintained (VLO) at Buy and Held Target at $104 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Carl Murdock-Smith Downgraded (VOD) to Hold on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (VSCO) at Buy with Decreased Target to $70 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (VRTX) at Buy with Increased Target to $300 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (WLK) at Buy with Increased Target to $155 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Oppenheim Initiated (WHR) at Hold and Held Target at $180 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Caliendo Maintained (WBA) at Hold with Decreased Target to $49 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
George Hill Maintained (WBA) at Hold with Decreased Target to $46 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Initiated (WEX) at Buy and Held Target at $205 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Linda Bolton Weiser Downgraded (WDFC) to Sell and Decreased Target to $157 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (URBN) at Hold with Decreased Target to $28 on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Scott Group Downgraded (UPS) to Hold on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Upgraded (XYL) to Hold on, Apr 5th, 2022
[ 12:00 AM ] - WOPRAI
Arlinda Lee Maintained (XFOR) at Strong Buy with Decreased Target to $10 on, Apr 5th, 2022

Arlinda Lee Maintained (XFOR) at Strong Buy with Decreased Target to $10 on, Apr 5th, 2022


Published on 2024-10-27 20:17:49 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $20 to $10 on, Apr 5th, 2022.

Arlinda has made no other calls on XFOR in the last 4 months.



There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Arlinda's Rating of Hold.



This is the rating of the analyst that currently disagrees with Arlinda

  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, December 14th, 2021
Contributing Sources